A clinical trial to study the effects of two drugs, ondansetron versus hyoscine in patients undergoing cesarean section under spinal anaesthesia.
Phase 2
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/09/057985
- Lead Sponsor
- Dr Anwesha Bayan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Age group: 18 to 35 years
2. ASA physical status 2.
3. Normal singleton pregnancy with a gestational period of minimum 32 weeks.
4. Elective caesarean section under spinal anaesthesia.
5. Informed and written consent will be taken.
Exclusion Criteria
EXCLUSION CRITERIA:
1. Allergy to study drugs.
2. Patient with known coagulopathy or patients on anticoagulation therapy.
3. Patient’s height <150 or >180 cm.
4. Patient with pregnancy induced hypertension
5. Patient with gestational diabetes mellitus
6. Patient with fetal distress
7. Patient with cardiac disease
8. Patient with Kidney disease
9. Patient with morbid obesity
10. BMI >35 kg per metre square
11. baseline bradycardia (HR- 60 bpm) or tachycardia (HR more than or equal to 100 bpm)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the incidence of intraoperative bradycardia between the two groups.Timepoint: To compare the incidence of intraoperative bradycardia between the two groups at 0, 1, 3, 6, 9, 15, 20, 30, 40, 50 minutes.
- Secondary Outcome Measures
Name Time Method To compare fetal APGAR score between the two groups.Timepoint: At 1 minute & 5 minutes.;To compare the changes in intraoperative hemodynamics between the two groups.Timepoint: Intraoperatively.;To compare the incidence of intraoperative nausea & vomiting between the two groups.Timepoint: Intraoperatively.;To compare the incidence of post operative nausea & vomiting between the two groups.Timepoint: 2 hours.